×

ENTER REPORT NAME TO SEARCH

Global Antidote Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Report ID: GIR2106040553 | Category: Consumer Goods | Pages: 94 | Format: PDF | Published Date: October 22,2021


Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Antidote
    1.2 Classification of Antidote by Type
        1.2.1 Overview: Global Antidote Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Antidote Revenue Market Share by Type in 2020
        1.2.3 Chemical Antidotes
        1.2.4 Physical Antidotes
        1.2.5 Pharmacological Antidotes
    1.3 Global Antidote Market by Application
        1.3.1 Overview: Global Antidote Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Pesticide Poisoning
        1.3.3 Heavy Metal Poisoning
        1.3.4 Animal Bites Poisoning
        1.3.5 Cyanide Poisoning
        1.3.6 Others
    1.4 Global Antidote Market Size & Forecast
    1.5 Global Antidote Market Size and Forecast by Region
        1.5.1 Global Antidote Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Antidote Market Size by Region, (2016-2021)
        1.5.3 North America Antidote Market Size and Prospect (2016-2026)
        1.5.4 Europe Antidote Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Antidote Market Size and Prospect (2016-2026)
        1.5.6 South America Antidote Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Antidote Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Antidote Market Drivers
        1.6.2 Antidote Market Restraints
        1.6.3 Antidote Trends Analysis
2 Company Profiles
    2.1 Roche
        2.1.1 Roche Details
        2.1.2 Roche Major Business
        2.1.3 Roche Antidote Product and Solutions
        2.1.4 Roche Antidote Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Roche Recent Developments and Future Plans
    2.2 Pfizer
        2.2.1 Pfizer Details
        2.2.2 Pfizer Major Business
        2.2.3 Pfizer Antidote Product and Solutions
        2.2.4 Pfizer Antidote Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Pfizer Recent Developments and Future Plans
    2.3 Bayer
        2.3.1 Bayer Details
        2.3.2 Bayer Major Business
        2.3.3 Bayer Antidote Product and Solutions
        2.3.4 Bayer Antidote Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Bayer Recent Developments and Future Plans
    2.4 Johnson & Johnson
        2.4.1 Johnson & Johnson Details
        2.4.2 Johnson & Johnson Major Business
        2.4.3 Johnson & Johnson Antidote Product and Solutions
        2.4.4 Johnson & Johnson Antidote Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Johnson & Johnson Recent Developments and Future Plans
    2.5 Novartis
        2.5.1 Novartis Details
        2.5.2 Novartis Major Business
        2.5.3 Novartis Antidote Product and Solutions
        2.5.4 Novartis Antidote Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Novartis Recent Developments and Future Plans
    2.6 Eli Lilly
        2.6.1 Eli Lilly Details
        2.6.2 Eli Lilly Major Business
        2.6.3 Eli Lilly Antidote Product and Solutions
        2.6.4 Eli Lilly Antidote Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Eli Lilly Recent Developments and Future Plans
    2.7 Teva
        2.7.1 Teva Details
        2.7.2 Teva Major Business
        2.7.3 Teva Antidote Product and Solutions
        2.7.4 Teva Antidote Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Teva Recent Developments and Future Plans
    2.8 Boehringer Ingelheim
        2.8.1 Boehringer Ingelheim Details
        2.8.2 Boehringer Ingelheim Major Business
        2.8.3 Boehringer Ingelheim Antidote Product and Solutions
        2.8.4 Boehringer Ingelheim Antidote Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.9 Mylan
        2.9.1 Mylan Details
        2.9.2 Mylan Major Business
        2.9.3 Mylan Antidote Product and Solutions
        2.9.4 Mylan Antidote Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Mylan Recent Developments and Future Plans
    2.10 Fresenius Kabi 
        2.10.1 Fresenius Kabi Details
        2.10.2 Fresenius Kabi Major Business
        2.10.3 Fresenius Kabi Antidote Product and Solutions
        2.10.4 Fresenius Kabi Antidote Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Fresenius Kabi Recent Developments and Future Plans
    2.11 Baxter
        2.11.1 Baxter Details
        2.11.2 Baxter Major Business
        2.11.3 Baxter Antidote Product and Solutions
        2.11.4 Baxter Antidote Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Baxter Recent Developments and Future Plans
    2.12 Furen Pharmaceutical
        2.12.1 Furen Pharmaceutical Details
        2.12.2 Furen Pharmaceutical Major Business
        2.12.3 Furen Pharmaceutical Antidote Product and Solutions
        2.12.4 Furen Pharmaceutical Antidote Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Furen Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Antidote Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Antidote Players Market Share
        3.2.2 Top 10 Antidote Players Market Share
        3.2.3 Market Competition Trend
    3.3 Antidote Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Antidote Revenue and Market Share by Type (2016-2021)
    4.2 Global Antidote Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Antidote Revenue Market Share by Application (2016-2021)
    5.2 Antidote Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Antidote Revenue by Type (2016-2026)
    6.2 North America Antidote Revenue by Application (2016-2026)
    6.3 North America Antidote Market Size by Country
        6.3.1 North America Antidote Revenue by Country (2016-2026)
        6.3.2 United States Antidote Market Size and Forecast (2016-2026)
        6.3.3 Canada Antidote Market Size and Forecast (2016-2026)
        6.3.4 Mexico Antidote Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Antidote Revenue by Type (2016-2026)
    7.2 Europe Antidote Revenue by Application (2016-2026)
    7.3 Europe Antidote Market Size by Country
        7.3.1 Europe Antidote Revenue by Country (2016-2026)
        7.3.2 Germany Antidote Market Size and Forecast (2016-2026)
        7.3.3 France Antidote Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Antidote Market Size and Forecast (2016-2026)
        7.3.5 Russia Antidote Market Size and Forecast (2016-2026)
        7.3.6 Italy Antidote Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Antidote Revenue by Type (2016-2026)
    8.2 Asia-Pacific Antidote Revenue by Application (2016-2026)
    8.3 Asia-Pacific Antidote Market Size by Region
        8.3.1 Asia-Pacific Antidote Revenue by Region (2016-2026)
        8.3.2 China Antidote Market Size and Forecast (2016-2026)
        8.3.3 Japan Antidote Market Size and Forecast (2016-2026)
        8.3.4 South Korea Antidote Market Size and Forecast (2016-2026)
        8.3.5 India Antidote Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Antidote Market Size and Forecast (2016-2026)
        8.3.7 Australia Antidote Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Antidote Revenue by Type (2016-2026)
    9.2 South America Antidote Revenue by Application (2016-2026)
    9.3 South America Antidote Market Size by Country
        9.3.1 South America Antidote Revenue by Country (2016-2026)
        9.3.2 Brazil Antidote Market Size and Forecast (2016-2026)
        9.3.3 Argentina Antidote Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Antidote Revenue by Type (2016-2026)
    10.2 Middle East & Africa Antidote Revenue by Application (2016-2026)
    10.3 Middle East & Africa Antidote Market Size by Country
        10.3.1 Middle East & Africa Antidote Revenue by Country (2016-2026)
        10.3.2 Turkey Antidote Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Antidote Market Size and Forecast (2016-2026)
        10.3.4 UAE Antidote Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer